MAPT and Alzheimer disease: Collectively, leptin influences multiple pathological processes in AD, including the regulation of amyloid production and clearance, attenuation of tau pathology, inhibition of maladaptive neuroinflammation, and maintenance of synaptic network integrity, underscoring its potential as a therapeutic target.